B · Normal
[WuXi AppTec: AI is in the exploratory and trial stage in the field of innovative drug R&D and is expected to significantly improve efficiency and lower barriers to entry in the future] On September 30, WuXi AppTec stated on an interactive platform that AI is currently in the exploratory and trial stage in the field of innovative drug R&D. In the future, it is expected to significantly improve efficiency, lower barriers to entry, and promote the rapid growth of innovators and innovative ideas.
Comments